These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 34706132

  • 21. MicroRNA-130a-3p regulates osimertinib resistance by targeting runt-related transcription factor 3 in lung adenocarcinoma.
    Shintani T, Shun YT, Toyozumi Y, Ikemura K, Shiroyama T, Nagatomo I, Jingushi K, Takeda Y, Kumanogoh A, Okuda M.
    Sci Rep; 2024 Oct 18; 14(1):24429. PubMed ID: 39424918
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. CircRNA ZKSCAN1 promotes lung adenocarcinoma progression by miR-185-5p/TAGLN2 axis.
    Yu N, Gong H, Chen W, Peng W.
    Thorac Cancer; 2023 Jun 18; 14(16):1467-1476. PubMed ID: 37105934
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Hsa-miR-195-5p Inhibits Autophagy and Gemcitabine Resistance of Lung Adenocarcinoma Cells via E2F7/CEP55.
    Fu L, Li Z, Wu Y, Zhu T, Ma Z, Dong L, Ding J, Zhang C, Yu G.
    Biochem Genet; 2023 Aug 18; 61(4):1528-1547. PubMed ID: 36658310
    [Abstract] [Full Text] [Related]

  • 27. A Novel Acquired Exon 20 EGFR M766Q Mutation in Lung Adenocarcinoma Mediates Osimertinib Resistance but is Sensitive to Neratinib and Poziotinib.
    Castellano GM, Aisner J, Burley SK, Vallat B, Yu HA, Pine SR, Ganesan S.
    J Thorac Oncol; 2019 Nov 18; 14(11):1982-1988. PubMed ID: 31254668
    [Abstract] [Full Text] [Related]

  • 28. Circular RNA hsa_circ_0014130 Inhibits Apoptosis in Non-Small Cell Lung Cancer by Sponging miR-136-5p and Upregulating BCL2.
    Geng Y, Bao Y, Zhang W, Deng L, Su D, Zheng H.
    Mol Cancer Res; 2020 May 18; 18(5):748-756. PubMed ID: 32060230
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. CircMYBL1 suppressed acquired resistance to osimertinib in non-small-cell lung cancer.
    Li Y, Wang N, Huang Y, He S, Bao M, Wen C, Wu L.
    Cancer Genet; 2024 Jun 18; 284-285():34-42. PubMed ID: 38626533
    [Abstract] [Full Text] [Related]

  • 35. hsa_circ_0000729, a potential prognostic biomarker in lung adenocarcinoma.
    Li S, Sun X, Miao S, Lu T, Wang Y, Liu J, Jiao W.
    Thorac Cancer; 2018 Aug 18; 9(8):924-930. PubMed ID: 29932500
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Hsa_circ_0070440 promotes lung adenocarcinoma progression by SLC7A11-mediated-ferroptosis.
    Zhao Y, Cui Q, Shen J, Shen W, Weng Y.
    Histol Histopathol; 2023 Dec 18; 38(12):1429-1441. PubMed ID: 36852950
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.